On Demand 2024 Friday AM General Sessions

This course includes the following sessions from Friday morning's program:

  • Why Am I So Itchy?
  • Epinephrine Uncertainty
  • Looking Backwards to Look Forward
  • New Tools for the Management of Allergic Diseases

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Identify molecular, cellular and neural mechanism of the itch pathways.
  • Define classifications of itch and the various clinical presentations of cutaneous and systemic pruritus.
  • Interpret recent studies with an emphasis on the management for the patient with pruritus.
  • Identify anaphylaxis, including clinical features and key biomarkers that should be considered in acute allergic reactions.
  • Evaluate risks and benefits of home monitoring vs. healthcare setting monitoring after epinephrine administration.
  • Describe emerging options for epinephrine administration.
  • Describe modalities that can be employed in allergy practice and how their use could be tailored to a patient within an outpatient practice setting or how patients can be referred to appropriate practitioners.
  • Help patients with allergic conditions use meditation and incorporate cost effective, evidence-based modalities like meditation into their practice.
  • Develop tools to find the evidence for integrative modalities and distinguish between validated practices and those lacking adequate evidence. Understand how osteopathic manipulation may help allergy patients and how to find competent, credentialed practitioners that can perform such testing and treatments.
  • Perform the following activities through use of DHRs registries: (i) classify reactions and define endotypes; (ii) establish the role of the different diagnostic methods; (iii) understand the natural evolution; (iv) analyze the costs; and (iv) perform risk stratification.
  • Discuss the first results from the cross-sectional EAACI HEAD registry-based study collecting high quality data for the burden of allergic diseases and asthma from several European countries.
    Understand system biology approaches based on biological processes and systemic signatures to monitor interventions in allergy such as AIT.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.
Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
  • 6.00 CBRN
Course opens: 
11/11/2024
Course expires: 
11/10/2027
Part of: 
On Demand ACAAI 2024 Annual Scientific Meeting General Sessions
Rating: 
0

Sandra M. Gawchik, DO, FACAAI
Jaspreet Benipal, DO
Gil Yosipovitch, MD
Aaron M. Ver Heul, MD, PhD
Luz S. Fonacier, MD, FACAAI
Joseph P. Forester, DO, FACAAI
Sara Anvari, MD, MSc, FACAAI
Julia Elizabeth M Upton, MD
Marcus S. Shaker, MD, MSc, FACAAI
David B K Golden, MD, FACAAI
Sami L. Bahna, MD, DrPH, FACAAI
Olabunmi Agboola, MD
Atoosa Kourosh, MD, MPH, FACAAI
Gary K. Soffer, MD
Xiu-Min Li, MD, FACAAI
Matthew Barker, DO
Stefano DelGiacco, MD, PhD
Maria J. Torres, MD, PhD
Ioana O. Agache, MD
Domingo Barber-Hernandez, PhD

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
  • 6.00 CBRN
Please login or create an account to take this course.